Pharmacokinetics and pharmacodynamics as well as metabolism following orally and intravenously administered C14-glipizide, a new antidiabetic.
D000284:Administration, Oral; D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D002250:Carbon Radioisotopes; D003510:Cyclohexanes / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology / Q000652:urine; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology / Q000652:urine; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood; D008297:Male; D011719:Pyrazines / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology / Q000652:urine; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology / Q000652:urine; D013997:Time Factors
D001786:Blood Glucose; D002250:Carbon Radioisotopes; D003510:Cyclohexanes; D007004:Hypoglycemic Agents; D007328:Insulin; D011719:Pyrazines; D013453:Sulfonylurea Compounds